Investors 1
| Date | Name | Website |
| 10.07.2026 | Novatio Ve... | novatioven... |
Mentions in press and media 1
| Date | Title | Description |
| 30.09.2024 | 3io Therapeutics Announces the Appointment of Dr. Michael Tusche as Chief Executive Officer | 3io’s highly innovative and differentiated viral immunotherapy platform represents a new paradigm in the use of virus-based, immuno-stimulating therapies in the fight against hard-to-treat cancers” — Michael TuscheTORONTO, ONTARIO, CANADA, ... |